Literature DB >> 18563540

Structure-activity relationships and organ specificity in the induction of GST and NQO1 by alkyl-aryl isothiocyanates.

Rex Munday1, Yuesheng Zhang, Christine M Munday, Meghana V Bapardekar, Joseph D Paonessa.   

Abstract

PURPOSE: To compare the ability of alkyl-aryl isothiocyanates (ITCs) to increase the activities of the Phase 2 detoxification enzymes NAD[P]H:quinone acceptor oxidoreductase 1 (NQO1) and glutathione S-transferases (GST) in rat tissues in vivo and in cells in vitro.
MATERIALS AND METHODS: Twelve alkyl-aryl ITCs and the fully-reduced derivative of benzyl ITC (cyclohexylmethyl ITC) were administered to rats each day for 5 days. The animals were then killed and organs harvested. The ITCs were also evaluated in a bladder cell line in culture. The activities of NQO1 and GST in the organs and cells were measured.
RESULTS: In vivo, the organ most susceptible to the inductive activity of the ITCs was the urinary bladder, with alpha-methylbenzyl ITC and cyclohexylmethyl ITC being the most effective. Inductive activity in the bladder in vivo did not, however, correlate with that in bladder cells in vitro.
CONCLUSIONS: Induction of Phase 2 enzymes increases resistance to chemical carcinogenesis. ITCs could therefore be valuable chemopreventative agents, and the specificity of these substances toward the urinary bladder suggest that they could be particularly useful for protecting against bladder cancer. In this regard, alpha-methylbenzyl ITC and cyclohexylmethyl ITC could be especially valuable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563540      PMCID: PMC2593848          DOI: 10.1007/s11095-008-9595-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  36 in total

1.  Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  Kazushi Okazaki; Megumi Yamagishi; Hwa-Young Son; Takayoshi Imazawa; Fumio Furukawa; Hideaki Nakamura; Akiyoshi Nishikawa; Toshiaki Masegi; Masao Hirose
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

3.  The metabolism of benzyl isothiocyanate and its cysteine conjugate.

Authors:  G Brüsewitz; B D Cameron; L F Chasseaud; K Görler; D R Hawkins; H Koch; W H Mennicke
Journal:  Biochem J       Date:  1977-01-15       Impact factor: 3.857

Review 4.  Isothiocyanates in the chemoprevention of bladder cancer.

Authors:  Li Tang; Yuesheng Zhang
Journal:  Curr Drug Metab       Date:  2004-04       Impact factor: 3.731

Review 5.  Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action.

Authors:  Yuesheng Zhang
Journal:  Mutat Res       Date:  2004-11-02       Impact factor: 2.433

6.  Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds.

Authors:  Rex Munday; Christine M Munday
Journal:  J Agric Food Chem       Date:  2004-04-07       Impact factor: 5.279

7.  Induction of DT-diaphorase by anticarcinogenic sulfur compounds in mice.

Authors:  A M Benson; P B Barretto; J S Stanley
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

8.  Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds.

Authors:  L W Wattenberg
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

9.  An association between NQO1 genetic polymorphism and risk of bladder cancer.

Authors:  Seun-Ja Park; Hua Zhao; Margaret R Spitz; H Barton Grossman; Xifeng Wu
Journal:  Mutat Res       Date:  2003-04-20       Impact factor: 2.433

10.  Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates.

Authors:  M A Morse; K I Eklind; S G Amin; S S Hecht; F L Chung
Journal:  Carcinogenesis       Date:  1989-09       Impact factor: 4.944

View more
  3 in total

Review 1.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

2.  A general and facile one-pot process of isothiocyanates from amines under aqueous conditions.

Authors:  Nan Sun; Bin Li; Jianping Shao; Weimin Mo; Baoxiang Hu; Zhenlu Shen; Xinquan Hu
Journal:  Beilstein J Org Chem       Date:  2012-01-10       Impact factor: 2.883

3.  Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials.

Authors:  Seokuee Kim; SeungHwan Lee; Joo-Youn Cho; Seo Hyun Yoon; In-Jin Jang; Kyung-Sang Yu
Journal:  Drug Des Devel Ther       Date:  2017-11-07       Impact factor: 4.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.